MUTATION SPECTRUM OF 4-NITROQUINOLINE 1-OXIDE-DAMAGED SINGLE-STRANDED SHUTTLE VECTOR DNA TRANSFECTED INTO MONKEY CELLS

被引:9
作者
FRONZA, G
MADZAK, C
CAMPOMENOSI, P
INGA, A
IANNONE, R
ABBONDANDOLO, A
SARASIN, A
机构
[1] INST RECH SCI CANC,GENET MOLEC LAB,F-94801 VILLEJUIF,FRANCE
[2] UNIV GENOA,CHAIR GENET,GENOA,ITALY
来源
MUTATION RESEARCH | 1994年 / 308卷 / 02期
关键词
4-NITROQUINOLINE 1-OXIDE MUTATION SPECTRUM; SHUTTLE VECTOR; SUPF;
D O I
10.1016/0027-5107(94)90146-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
4-Nitroquinoline 1-oxide (4NQO) is a potent mutagen and carcinogen which induces two main guanine adducts at positions C8 and N2. We recently determined the mutation spectrum induced by the ultimate metabolite of 4NQO, acetoxy-4-aminoquinoline 1-oxide in the M13lacZ'/E. coli lacZ Delta M15 alpha-complementation assay. Our data suggested that dGuo-C8-AQO induces (per se or via AP sites) G to Pyr transversions. Here we report our study on 4NQO mutagenesis in monkey cells. 4NQO lesions were induced in vitro on a single-stranded (ss) DNA shuttle vector carrying the supF tRNA gene. This vector was able to replicate both in mammalian cells and in bacteria. The mutations induced in monkey cells were screened by the white/blue beta-galactosidase activity assay in E. coli. We took advantage of the peculiar feature of ss supF DNA in which the extent of secondary structure may be a function of the temperature, with the dependence of the 4NQO-specific adduct spectrum on DNA secondary structure. We reasoned that mutational spectra derived from damage induced in the presence (20 degrees C) or absence (70 degrees C) of DNA secondary structure should be different. The result of sequencing a total of 89 induced and spontaneous mutants confirmed that the spectra are statistically different. These data suggest that the two 4NQO guanine adducts may induce different mutations.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 35 条
[1]  
BAILLEUL B, 1981, CANCER RES, V41, P4559
[2]   CONFORMATIONS OF POLY(DG-DC).POLY(DG-DC) MODIFIED BY THE O-ACETYL DERIVATIVE OF THE CARCINOGEN 4-HYDROXYAMINOQUINOLINE 1-OXIDE [J].
BAILLEUL, B ;
GALIEGUEZOUITINA, S ;
LOUCHEUXLEFEBVRE, MH .
NUCLEIC ACIDS RESEARCH, 1984, 12 (20) :7915-7927
[3]   IDENTIFICATION OF 4-ACETOXYAMINOQUINOLINE FROM THE HYDROLYSIS OF 1-ACETOXY-4-ACETOXYIMINO-1,4-DIHYDROQUINOLINE, INVITRO AND INVIVO PROPERTIES [J].
BAILLEUL, B ;
GALIEGUE, S ;
DEMEUNYNCK, M ;
LHOMME, MF ;
LHOMME, J ;
LOUCHEUXLEFEBVRE, MH .
CHEMICO-BIOLOGICAL INTERACTIONS, 1983, 43 (01) :87-98
[4]   MOLECULAR-BASIS OF 4-NITROQUINOLINE 1-OXIDE CARCINOGENESIS [J].
BAILLEUL, B ;
DAUBERSIES, P ;
GALIEGUEZOUITINA, S ;
LOUCHEUXLEFEBVRE, MH .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (08) :691-697
[5]   PSORALEN ADDUCTS IN A SHUTTLE VECTOR PLASMID PROPAGATED IN PRIMATE CELLS - HIGH MUTAGENICITY OF DNA CROSS-LINKS [J].
BREDBERG, A ;
NACHMANSSON, N .
CARCINOGENESIS, 1987, 8 (12) :1923-1927
[6]   MUTATION SPECTRA OF THE 2 GUANINE ADDUCTS OF THE CARCINOGEN 4-NITROQUINOLINE 1-OXIDE IN ESCHERICHIA-COLI - INFLUENCE OF NEIGHBORING BASE SEQUENCE ON MUTAGENESIS [J].
DAUBERSIES, P ;
GALIEGUEZOUITINA, S ;
KOFFELSCHWARTZ, N ;
FUCHS, RPP ;
LOUCHEUXLEFEBVRE, MH ;
BAILLEUL, B .
CARCINOGENESIS, 1992, 13 (03) :349-354
[7]   EXTENT OF HELIX PERTURBATION ASSOCIATED WITH DNA MODIFICATION BY THE O-ACETYL DERIVATIVE OF THE CARCINOGEN 4-HYDROXYAMINOQUINOLINE-1-OXIDE [J].
FRONZA, G ;
TORNALETTI, S ;
MENICHINI, P ;
GALIEGUEZOUITINA, S ;
BAILLEUL, B ;
LOUCHEUXLEFEBVRE, MH ;
ABBONDANDOLO, A ;
PEDRINI, AM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1087 (03) :330-335
[8]   THE 4-NITROQUINOLINE 1-OXIDE MUTATIONAL SPECTRUM IN SINGLE-STRANDED-DNA IS CHARACTERIZED BY GUANINE TO PYRIMIDINE TRANSVERSIONS [J].
FRONZA, G ;
CAMPOMENOSI, P ;
IANNONE, R ;
ABBONDANDOLO, A .
NUCLEIC ACIDS RESEARCH, 1992, 20 (06) :1283-1287
[9]  
GALIEGUEZOUITINA S, 1985, CANCER RES, V45, P520
[10]   GUANYL-C-8-ARYLAMINATION OF DNA BY THE ULTIMATE CARCINOGEN OF 4-NITROQUINOLINE-1-OXIDE - A SPECTROPHOTOMETRIC TITRATION [J].
GALIEGUEZOUITINA, S ;
BAILLEUL, B ;
LOUCHEUXLEFEBVRE, MH .
ANALYTICAL BIOCHEMISTRY, 1984, 138 (02) :454-457